154 related articles for article (PubMed ID: 24622084)
61. KIT-negative gastrointestinal stromal tumor of the abdominal soft tissue: a clinicopathologic and genetic study of 10 cases.
Yamamoto H; Kojima A; Nagata S; Tomita Y; Takahashi S; Oda Y
Am J Surg Pathol; 2011 Sep; 35(9):1287-95. PubMed ID: 21836495
[TBL] [Abstract][Full Text] [Related]
62. False-Positive Pancreastatin Results From a Commercial Laboratory: A Report of 2 Cases.
Sagum J; Yu R
Pancreas; 2021 Mar; 50(3):e33-e35. PubMed ID: 33835984
[No Abstract] [Full Text] [Related]
63. Primary hepatic neuroendocrine tumor with exophytic growth: report of a case with diagnosis by fine needle aspiration biopsy.
Skagias L; Vasou O; Ntinis A; Kondi-Pafiti A; Koureas A; Politi E
Acta Cytol; 2010; 54(2):202-4. PubMed ID: 20391980
[TBL] [Abstract][Full Text] [Related]
64. Gastrointestinal stromal tumour of the duodenum in a 7-year-old boy.
Hughes JA; Cook JV; Said A; Chong SK; Towu E; Reidy J
Pediatr Radiol; 2004 Dec; 34(12):1024-7. PubMed ID: 15490151
[TBL] [Abstract][Full Text] [Related]
65. Duodenal carcinoid tumor: report of a case diagnosed by endoscopic ultrasound-guided fine-needle aspiration biopsy with immunocytochemical correlation.
Acs G; McGrath CM; Gupta PK
Diagn Cytopathol; 2000 Sep; 23(3):183-6. PubMed ID: 10945906
[TBL] [Abstract][Full Text] [Related]
66. Clinical, pathologic, and immunohistochemical characteristics of gastrointestinal stromal tumors of the colon and rectum: implications for surgical management and adjuvant therapies.
Hassan I; You YN; Dozois EJ; Shayyan R; Smyrk TC; Okuno SH; Donohue JH
Dis Colon Rectum; 2006 May; 49(5):609-15. PubMed ID: 16552495
[TBL] [Abstract][Full Text] [Related]
67. [Gastrointestinal stromal tumors].
Guzińska-Ustymowicz K; Nasierowska-Guttmejer A
Pol J Pathol; 2013 Dec; 64(4 Suppl 2):s47-54. PubMed ID: 24893508
[No Abstract] [Full Text] [Related]
68. NKX6-1 Is a Novel Immunohistochemical Marker for Pancreatic and Duodenal Neuroendocrine Tumors.
Tseng IC; Yeh MM; Yang CY; Jeng YM
Am J Surg Pathol; 2015 Jun; 39(6):850-7. PubMed ID: 25871618
[TBL] [Abstract][Full Text] [Related]
69. Immunohistochemical diagnosis of gastrointestinal stromal tumors - an analysis of 80 cases from 2004 to 2010.
Kiśluk J; Gryko M; Guzińska-Ustymowicz K; Kemona A; Kędra B
Adv Clin Exp Med; 2013; 22(1):33-9. PubMed ID: 23468260
[TBL] [Abstract][Full Text] [Related]
70. Pancreatic expression of DOG1: a novel gastrointestinal stromal tumor (GIST) biomarker.
Ardeleanu C; Arsene D; Hinescu M; Andrei F; Gutu D; Luca L; Popescu LM
Appl Immunohistochem Mol Morphol; 2009 Oct; 17(5):413-8. PubMed ID: 19417627
[TBL] [Abstract][Full Text] [Related]
71. Synchronous presentation of GISTs and other primary neoplasms: a single center experience.
Arnogiannaki N; Martzoukou I; Kountourakis P; Dimitriadis E; Papathanasaki A; Nastoulis E; Gazalidou M; Fida A; Apostolikas N; Agnantis NJ
In Vivo; 2010; 24(1):109-15. PubMed ID: 20133985
[TBL] [Abstract][Full Text] [Related]
72. DOG1 antibody is a highly sensitive and specific marker for gastrointestinal stromal tumors in cytology cell blocks.
Hwang DG; Qian X; Hornick JL
Am J Clin Pathol; 2011 Mar; 135(3):448-53. PubMed ID: 21350101
[TBL] [Abstract][Full Text] [Related]
73. Functional role of the Ca²⁺-activated Cl⁻ channel DOG1/TMEM16A in gastrointestinal stromal tumor cells.
Berglund E; Akcakaya P; Berglund D; Karlsson F; Vukojević V; Lee L; Bogdanović D; Lui WO; Larsson C; Zedenius J; Fröbom R; Bränström R
Exp Cell Res; 2014 Aug; 326(2):315-25. PubMed ID: 24825187
[TBL] [Abstract][Full Text] [Related]
74. Clinicopathologic features, cellular differentiation, PCNA and P53 expressions in gastrointestinal stromal tumors.
Can B; Sökmensüer C
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxliii-ccxlviii. PubMed ID: 15244191
[TBL] [Abstract][Full Text] [Related]
75. Diagnosis of functioning pancreaticoduodenal neuroendocrine tumors.
Imamura M; Nakamoto Y; Uose S; Komoto I; Awane M; Taki Y
J Hepatobiliary Pancreat Sci; 2015 Aug; 22(8):602-9. PubMed ID: 25624017
[TBL] [Abstract][Full Text] [Related]
76. Extensive calcification within a gastrointestinal stromal tumour: a potential diagnostic pitfall.
Ong K; Singaporewalla RM; Tan KB
Pathology; 2006 Oct; 38(5):451-2. PubMed ID: 17008287
[No Abstract] [Full Text] [Related]
77. Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum.
Woltering EA; Beyer DT; Thiagarajan R; Ramirez RA; Wang YZ; Ricks MJ; Boudreaux JP
J Am Coll Surg; 2016 Apr; 222(4):534-42. PubMed ID: 26827125
[TBL] [Abstract][Full Text] [Related]
78. [Chinese pathologic consensus for standard diagnosis of gastrointestinal and pancreatic neuroendocrine neoplasm].
Chinese Pathologic Consensus Group for Gastrointestinal and Pancreatic Neuroendocrine Neoplasm
Zhonghua Bing Li Xue Za Zhi; 2011 Apr; 40(4):257-62. PubMed ID: 21616002
[No Abstract] [Full Text] [Related]
79. Synchronous Gastrointestinal Stromal Tumor and Ampullary Neuroendocrine Tumor in Association with Neurofibromatosis Type 1: A Report of Three Cases.
Park EK; Kim HJ; Lee YH; Koh YS; Hur YH; Cho CK
Korean J Gastroenterol; 2019 Oct; 74(4):227-231. PubMed ID: 31650799
[TBL] [Abstract][Full Text] [Related]
80. Primary duodenal neoplasms: a retrospective clinico-pathological analysis.
Bal A; Joshi K; Vaiphei K; Wig JD
World J Gastroenterol; 2007 Feb; 13(7):1108-11. PubMed ID: 17373748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
